申请人:Shionogi & Co., Ltd.
公开号:US20170349587A1
公开(公告)日:2017-12-07
The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.